Patents by Inventor Robert A. Silverman

Robert A. Silverman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240423963
    Abstract: Methods for the treatment of cutaneous vascular conditions and cutaneous proliferative conditions are provided. The methods employ topical administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus (rapamycin) and everolimus. Conditions treatable by the disclosed methods include venolymphatic malformations, acne, acne rosacea, periorificial dermatitis, acne vulgaris, cutaneous capillary malformation-arteriovenous malformation (CM-AVM) syndrome, RASopathies, Langerhans cell histiocytosis, non-Langerhans cell histiocytosis, scars, hypertrophic or keloidal scars, Proteus syndrome, PIK3CA-related overgrowth spectrum (PROS), PTEN hamartoma tumor syndromes, cutaneous malignancies and tumors associated with PI3K/AKT/mTOR mutations, keratodermas, acanthosis nigricans, Birt-Hogg-Dubé syndrome, Brooke-Speigler syndrome, cylindromas, and epidermal nevi.
    Type: Application
    Filed: September 4, 2024
    Publication date: December 26, 2024
    Inventors: Cynthia Marie Carver DEKLOTZ, Robert A. SILVERMAN
  • Patent number: 12109199
    Abstract: Methods for the treatment of cutaneous vascular conditions and cutaneous proliferative conditions are provided. The methods employ topical administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus (rapamycin) and everolimus. Conditions treatable by the disclosed methods include venolymphatic malformations, acne, acne rosacea, periorificial dermatitis, acne vulgaris, cutaneous capillary malformation-arteriovenous malformation (CM-AVM) syndrome, RASopathies, Langerhans cell histiocytosis, non-Langerhans cell histiocytosis, scars, hypertrophic or keloidal scars, Proteus syndrome, PIK3CA-related overgrowth spectrum (PROS), PTEN hamartoma tumor syndromes, cutaneous malignancies and tumors associated with PI3K/AKT/mTOR mutations, keratodermas, acanthosis nigricans, Birt-Hogg-Dube syndrome, Brooke-Speigler syndrome, cylindromas, and epidermal nevi.
    Type: Grant
    Filed: February 6, 2019
    Date of Patent: October 8, 2024
    Assignee: Georgetown University
    Inventors: Cynthia Marie Carver Deklotz, Robert A. Silverman
  • Publication number: 20210177810
    Abstract: Methods for the treatment of cutaneous vascular conditions and cutaneous proliferative conditions are provided. The methods employ topical administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus (rapamycin) and everolimus. Conditions treatable by the disclosed methods include venolymphatic malformations, acne, acne rosacea, periorificial dermatitis, acne vulgaris, cutaneous capillary malformation-arteriovenous malformation (CM-AVM) syndrome, RASopathies, Langerhans cell histiocytosis, non-Langerhans cell histiocytosis, scars, hypertrophic or keloidal scars, Proteus syndrome, PIK3CA-related overgrowth spectrum (PROS), PTEN hamartoma tumor syndromes, cutaneous malignancies and tumors associated with PI3K/AKT/mTOR mutations, keratodermas, acanthosis nigricans, Birt-Hogg-Dube syndrome, Brooke-Speigler syndrome, cylindromas, and epidermal nevi.
    Type: Application
    Filed: February 6, 2019
    Publication date: June 17, 2021
    Inventors: Cynthia Marie Carver DEKLOTZ, Robert A. SILVERMAN
  • Publication number: 20210137897
    Abstract: Methods for the treatment of cutaneous vascular conditions and cutaneous proliferative conditions are provided. The methods employ topical administration of mammalian target of rapamycin (mTOR) inhibitors such as sirolimus (rapamycin) and everolimus. Conditions treatable by the disclosed methods include venolymphatic malformations, acne, acne rosacea, periorificial dermatitis, acne vulgaris, cutaneous capillary malformation-arteriovenous malformation (CM-AVM) syndrome, RASopathies, Langerhans cell histiocytosis, non-Langerhans cell histiocytosis, scars, hypertrophic or keloidal scars, Proteus syndrome, PIK3CA-related overgrowth spectrum (PROS), PTEN hamartoma tumor syndromes, cutaneous malignancies and tumors associated with PI3K/AKT/mTOR mutations, keratodermas, acanthosis nigricans, Birt-Hogg-Dubé syndrome, Brooke-Speigler syndrome, cylindromas, epidermal nevi, and confluent and reticulated papillomatosis (CARP).
    Type: Application
    Filed: October 22, 2020
    Publication date: May 13, 2021
    Inventors: Cynthia Marie Carver DeKlotz, Robert A. Silverman
  • Patent number: 4444874
    Abstract: Photographic elements particularly adapted for forming direct-positive images are disclosed in which a radiation-sensitive core-shell emulsion layer and a silver halide emulsion layer incapable of forming a surface latent image within the direct-positive exposure latitude of the first emulsion layer and containing a grain population capable of internally trapping photolytically generated electrons are both present. The photographic elements are capable of exhibiting increased covering power, greater maximum density, and increased speed.
    Type: Grant
    Filed: September 15, 1982
    Date of Patent: April 24, 1984
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Harry A. Hoyen
  • Patent number: 4444865
    Abstract: Blended emulsions for use in forming a direct-positive image are disclosed. The emulsions are comprised of a first, radiation-sensitive core-shell grain population having a relatively low coefficient of variation and a second, substantially smaller size grain population capable of internally trapping photolytically generated electrons. Photographic elements incorporating the blended emulsions exhibit improved covering power and can exhibit enhanced speed.
    Type: Grant
    Filed: September 15, 1982
    Date of Patent: April 24, 1984
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Harry A. Hoyen
  • Patent number: 4433047
    Abstract: Photographic elements particularly adapted for forming direct-positive images are disclosed in which a radiation-sensitive core-shell emulsion layer and a silver halide emulsion layer incapable of forming a surface latent image within the direct-positive exposure latitude of the first emulsion layer and containing a grain population capable of internally trapping photolytically generated electrons are both present. The photographic elements are capable of exhibiting increased covering power, greater maximum density, and increased speed.
    Type: Grant
    Filed: September 15, 1982
    Date of Patent: February 21, 1984
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Harry A. Hoyen
  • Patent number: 3957882
    Abstract: Photographic elements are disclosed containing a hydrophilic colloid layer hardened with a compound having the structural formula:XCH.sub.2 CH.sub.2 SO.sub.2 Q(OQ).sub.m SO.sub.2 CH.sub.2 CH.sub.2 Xwherein X in each occurrence is halogen, Q is an aliphatic or phenyl substituted aliphatic divalent hydrocarbon radical having from 1 to 6 aliphatic carbon atoms and m is an integer of from 0 to 3 inclusive. The hardener also serves as an anti-foggant in photographic applications. Preferred are novel hardening and anti-fogging compounds having the structural formula: ##EQU1## in which X is halogen and R is hydrogen, phenyl or alkyl having from 1 to 6 carbon atoms.
    Type: Grant
    Filed: May 2, 1974
    Date of Patent: May 18, 1976
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Charles J. Wright
  • Patent number: RE29305
    Abstract: Photographic elements are disclosed containing a hydrophilic colloid layer hardened with a compound having two vinylsulfonyl radicals coupled through a divalent hydrocarbon radical chosen from the group consisting of (1) an aliphatic radical having from 1 to 6 carbon atoms, (2) --X--Y--X-- in which X is an alkylene group having 1 or 2 carbon atoms and Y is a phenylene group and (3) a phenyl-substituted methylene group. The compounds may be utilized generally in hardenable hydrophilic colloid compositions. Except for those compounds incorporating an alkylene divalent hydrocarbon radical, the hardeners are new compounds. .Iadd.
    Type: Grant
    Filed: October 15, 1976
    Date of Patent: July 12, 1977
    Assignee: Eastman Kodak Company
    Inventors: Donald M. Burness, Robert A. Silverman
  • Patent number: RE32097
    Abstract: Blended emulsions for use in forming a direct-positive image are disclosed. The emulsions are comprised of a first, radiation-sensitive core-shell grain population having a relatively low coefficient of variation and a second, substantially smaller size grain population capable of .Iadd.internally forming a latent image by .Iaddend.internally trapping photolytically generated electrons. Photographic elements incorporating the blended emulsions exhibit improved covering power and can exhibit enhanced speed.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: March 25, 1986
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Harry A. Hoyen
  • Patent number: RE32149
    Abstract: Photographic elements particularly adapted for forming direct-positive images are disclosed in which a radiation-sensitive core-shell emulsion layer and a silver halide emulsion layer incapable of forming a surface latent image within the direct-positive exposure latitude of the first emulsion layer and containing a grain population capable of internally .Iadd.forming a latent image by internally .Iaddend.trapping photolytically generated electrons are both present. The photographic elements are capable of exhibiting increased covering power, greater maximum density, and increased speed.
    Type: Grant
    Filed: July 2, 1984
    Date of Patent: May 20, 1986
    Assignee: Eastman Kodak Company
    Inventors: Robert A. Silverman, Harry A. Hoyen